Viewing Study NCT05971251


Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2025-12-25 @ 9:43 PM
Study NCT ID: NCT05971251
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-01
First Post: 2023-07-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Addition of Loncastuximab Tesirine to Acalbrutinib , Chronic Lymphocytic Leukemia
Sponsor: University of Alabama at Birmingham
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module